A Phase 1, Randomized, Open-Label, 3-Period, Crossover, Single-Dose, 2-Part Study in Healthy Participants to Investigate the Effect of Tablet Formulation and Food on the Relative Bioavailability of PF-06821497

A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants

Category & Conditions: Cancer

Medicine: PF-06821497

ClinicalTrials.gov Identifier (NCT): NCT05767905

Protocol ID: C2321005

Print Download

Open Plain Language Summary Result: Click here